176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
14.94%
Revenue growth above 1.5x MU's 1.29%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
16.15%
Gross profit growth above 1.5x MU's 3.11%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
24.95%
Positive EBIT growth while MU is negative. John Neff might see a substantial edge in operational management.
24.95%
Positive operating income growth while MU is negative. John Neff might view this as a competitive edge in operations.
24.16%
Positive net income growth while MU is negative. John Neff might see a big relative performance advantage.
23.38%
Positive EPS growth while MU is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
23.68%
Positive diluted EPS growth while MU is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.36%
Share change of 0.36% while MU is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
0.16%
Diluted share change of 0.16% while MU is zero. Bruce Berkowitz might see a minor difference that could widen over time.
0.65%
Dividend growth of 0.65% while MU is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
43.12%
Positive OCF growth while MU is negative. John Neff would see this as a clear operational advantage vs. the competitor.
58.57%
FCF growth 1.25-1.5x MU's 51.11%. Bruce Berkowitz would see if capex decisions or cost controls create a cash flow advantage.
517.62%
10Y revenue/share CAGR above 1.5x MU's 230.83%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
290.42%
5Y revenue/share CAGR above 1.5x MU's 64.52%. David Dodd would look for consistent product or market expansions fueling outperformance.
102.92%
3Y revenue/share CAGR above 1.5x MU's 32.84%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
3054.94%
10Y OCF/share CAGR above 1.5x MU's 455.12%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
1148.88%
5Y OCF/share CAGR above 1.5x MU's 153.61%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
186.10%
3Y OCF/share CAGR above 1.5x MU's 5.15%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
1411.18%
Net income/share CAGR 1.25-1.5x MU's 987.30%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
703.97%
5Y net income/share CAGR above 1.5x MU's 148.61%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
110.00%
3Y net income/share CAGR above 1.5x MU's 39.15%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
453.02%
10Y equity/share CAGR in line with MU's 422.40%. Walter Schloss might see both benefiting from stable profitability and moderate payout ratios over the decade.
304.44%
5Y equity/share CAGR 1.25-1.5x MU's 228.90%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
134.17%
3Y equity/share CAGR above 1.5x MU's 37.79%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
38.19%
Dividend/share CAGR of 38.19% while MU is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
7.02%
3Y dividend/share CAGR of 7.02% while MU is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
18.58%
AR growth well above MU's 2.55%. Michael Burry fears inflated revenue or higher default risk in the near future.
6.12%
Inventory growth well above MU's 11.52%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
25.50%
Asset growth above 1.5x MU's 4.00%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
12.23%
BV/share growth above 1.5x MU's 4.22%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
63.60%
Debt growth far above MU's 0.87%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
7.98%
R&D growth drastically higher vs. MU's 11.24%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
1.15%
SG&A growth well above MU's 1.54%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.